Thiothixene
Navane (thiothixene) is a small molecule pharmaceutical. Thiothixene was first approved as Navane on 1982-01-01. It is used to treat psychotic disorders, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 2A. In addition, it is known to target histamine H1 receptor.
Trade Name | Navane |
---|---|
Common Name | Thiothixene |
Indication | psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders |
Drug Class | Typical antipsychotic |